<DOC>
	<DOC>NCT01905163</DOC>
	<brief_summary>This prospective nonrandomized multicenter phase II study, will evaluate the possibility of performing a laparoscopic interval debulking after a minimum of 3 cycles of chemotherapy in highly chemo-sensitive patients with advanced ovarian, tubal cancer or primary peritoneal.</brief_summary>
	<brief_title>Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients</brief_title>
	<detailed_description />
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>Age &gt; or = 18 years performance status WHO &lt; 2 Epithelial ovarian, fallopian tubes or primary peritoneal carcinoma (histologically confirmed) Unresectable disease because of FIGO stage IV disease proven by imaging (CT Scan or PET CT) and/or diffuse extensive carcinosis considered unresectable for advanced FIGO stage IIIc; or patients unable to support a radical primary surgery because of age, comorbidities or altered general condition. No previous debulking surgery before neoadjuvant chemotherapy. Patients treated with a minimum of 3 cycles of platinumbased neoadjuvant chemotherapy. Response to chemotherapy was radiologically confirmed (ScanTAP) prior to interval surgery: No evidence of peritoneal supramesocolic carcinomatosis ; Residual pelvic masses smaller than 10 cm ; Absence of suspect supracentimeter retroperitoneal lymphadenopathy able to read, write and understand French. Member of a Social Security scheme. written informed consent. Patient unable to support laparoscopy psychiatric condition or social or geographic situation that would impede appropriate study participation Concomitant participation in another clinical trial evaluating surgical treatment (interfering with the evaluation of the main endpoint)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Laparoscopy, interval debulking surgery</keyword>
</DOC>